Cargando…
Regulatory T Cell Metabolism in Atherosclerosis
Regulatory T cells (Tregs) are capable of suppressing excessive immune responses to prevent autoimmunity and chronic inflammation. Decreased numbers of Tregs and impaired suppressive function are associated with the progression of atherosclerosis, a chronic inflammatory disease of the arterial wall...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408402/ https://www.ncbi.nlm.nih.gov/pubmed/32650487 http://dx.doi.org/10.3390/metabo10070279 |
_version_ | 1783567824081387520 |
---|---|
author | Baardman, Jeroen Lutgens, Esther |
author_facet | Baardman, Jeroen Lutgens, Esther |
author_sort | Baardman, Jeroen |
collection | PubMed |
description | Regulatory T cells (Tregs) are capable of suppressing excessive immune responses to prevent autoimmunity and chronic inflammation. Decreased numbers of Tregs and impaired suppressive function are associated with the progression of atherosclerosis, a chronic inflammatory disease of the arterial wall and the leading cause of cardiovascular disease. Therefore, therapeutic strategies to improve Treg number or function could be beneficial to preventing atherosclerotic disease development. A growing body of evidence shows that intracellular metabolism of Tregs is a key regulator of their proliferation, suppressive function, and stability. Here we evaluate the role of Tregs in atherosclerosis, their metabolic regulation, and the links between their metabolism and atherosclerosis. |
format | Online Article Text |
id | pubmed-7408402 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74084022020-08-13 Regulatory T Cell Metabolism in Atherosclerosis Baardman, Jeroen Lutgens, Esther Metabolites Review Regulatory T cells (Tregs) are capable of suppressing excessive immune responses to prevent autoimmunity and chronic inflammation. Decreased numbers of Tregs and impaired suppressive function are associated with the progression of atherosclerosis, a chronic inflammatory disease of the arterial wall and the leading cause of cardiovascular disease. Therefore, therapeutic strategies to improve Treg number or function could be beneficial to preventing atherosclerotic disease development. A growing body of evidence shows that intracellular metabolism of Tregs is a key regulator of their proliferation, suppressive function, and stability. Here we evaluate the role of Tregs in atherosclerosis, their metabolic regulation, and the links between their metabolism and atherosclerosis. MDPI 2020-07-08 /pmc/articles/PMC7408402/ /pubmed/32650487 http://dx.doi.org/10.3390/metabo10070279 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Baardman, Jeroen Lutgens, Esther Regulatory T Cell Metabolism in Atherosclerosis |
title | Regulatory T Cell Metabolism in Atherosclerosis |
title_full | Regulatory T Cell Metabolism in Atherosclerosis |
title_fullStr | Regulatory T Cell Metabolism in Atherosclerosis |
title_full_unstemmed | Regulatory T Cell Metabolism in Atherosclerosis |
title_short | Regulatory T Cell Metabolism in Atherosclerosis |
title_sort | regulatory t cell metabolism in atherosclerosis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408402/ https://www.ncbi.nlm.nih.gov/pubmed/32650487 http://dx.doi.org/10.3390/metabo10070279 |
work_keys_str_mv | AT baardmanjeroen regulatorytcellmetabolisminatherosclerosis AT lutgensesther regulatorytcellmetabolisminatherosclerosis |